Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Maculopathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01245387
What this trial is testing

Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related Macular DegenerationNeovascular Macular Degeneration
Pfizer 1,001
Not applicableStudy completedNCT01480700
What this trial is testing

Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular Pigment

Who this might be right for
Age-related Macular Degeneration
Institut Pasteur de Lille 99
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Testing effectiveness (Phase 2)Ended earlyNCT00414206
What this trial is testing

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
CoMentis 343
Testing effectiveness (Phase 2)Study completedNCT06164587
What this trial is testing

Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Inflammasome Therapeutics 30
Large-scale testing (Phase 3)Study completedNCT00523406
What this trial is testing

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

Who this might be right for
Macular Degeneration
Medical University of Vienna 40
Large-scale testing (Phase 3)Study completedNCT05161806
What this trial is testing

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Sandoz 30
Not applicableNot Yet RecruitingNCT05914233
What this trial is testing

Non-invasive Ultrasound Retinal Stimulation for Vision Restoration

Who this might be right for
Age-Related Macular DegenerationRetinitis PigmentosaUltrasound Therapy; Complications
University of Southern California 5
Testing effectiveness (Phase 2)Study completedNCT00766649
What this trial is testing

Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 11
Very early researchLooking for participantsNCT07053358
What this trial is testing

Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients

Who this might be right for
Neovascular Age-related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 10
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Testing effectiveness (Phase 2)Looking for participantsNCT07668804
What this trial is testing

Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy

Who this might be right for
Geographic Atrophy Due to Age-Related Macular Degeneration
Theratocular Biotek Co. 31
Not applicableEnded earlyNCT03794752
What this trial is testing

Visual Enhancement Device in Low Vision Patients

Who this might be right for
Macular Degeneration, Age-RelatedDiabetic Retinopathy
University of Texas Southwestern Medical Center 8
Large-scale testing (Phase 3)UnknownNCT06572553
What this trial is testing

Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients

Who this might be right for
Age-Related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Not applicableStudy completedNCT01846351
What this trial is testing

Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes

Who this might be right for
Epiretinal MembraneAge Related Macular Degeneration
New England Retina Associates 16
Early research (Phase 1)Study completedNCT00569140
What this trial is testing

A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116890
What this trial is testing

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Kyowa Kirin Co., Ltd. 180
Early research (Phase 1)Study completedNCT00791570
What this trial is testing

Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Who this might be right for
Neovascular MaculopathyAge Related Macular Degeneration
Osaka University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05984927
What this trial is testing

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Elisigen, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02121522
What this trial is testing

A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Boehringer Ingelheim 14
Next Page